DJE - Mittelstand & Innovation PA (EUR)

DJE - Mittelstand & Innovation PA (EUR) Header Image
ISIN:
LU1227570055
As at:
15/02/2018
Bid:
152.13 EUR
Offer:
159.74 EUR
The DJE – Mittelstand & Innovation is an equity fund focused on the German speaking countries Germany, Austria and Switzerland. Within these countries the investment priority is emphasized on innovative medium-sized enterprises with a promising growth potential and a market capitalization up to 5 Billion Euros. With more than 1500 enterprises the German speaking region forms the core region of the Hidden Champions. To be selected for the portfolio, these successful companies have to meet the following criteria: The market share is under top three of the world market respectively number one on the domestic market, the annual turnover is not higher than 3 Billion Euro and they are not well known. For several years these medium-sized companies have already been convincing with their strong innovational capacity, strong growth rates and with a high market share in structural growing (niche) markets. Because of the alternation of generations these mostly founder and family-run enterprises are listed at the stock exchange more and more frequently. With the appropriate knowledge various opportunities to benefit from this development are offered to the investor.

Legal Information / Disclaimer:

Figures subject to revision by the auditors on the reporting dates. The published information does not constitute investment advice or a recommendation, but only provides a brief summary of the key features of the fund. The current sales documents (Key Investor Information Document, prospectus, annual report and – if the annual report is older than eight months – the semi-annual report) for the respective investment funds form the sole basis for the purchase of securities. The sales documents are available at no charge at the respective fund company, the distribution company or at www.dje.de. All data and estimates are indicative and may change at any time. This information is based on our assessment of current legal and tax regulations. The data were carefully compiled, but no guarantee can be given for the accuracy of such information. All data are subject to change. The performance is calculated using the BVI (Bundesverband Investment und Asset Management e.V.) method, i.e. without taking into account the subscription fee. Individual expenses such as fees, commissions and other charges are not taken into account in the data and would have a detrimental effect on the performance if they were. The subscription fees payable reduce the invested capital as well as the performance depicted. Data on past performance are not a reliable indicator of future performance. The tax treatment depends on the individual circumstances of the investor and may be subject to change. Please see the prospectus for more detailed tax information. In connection with brokering fund units, the Dr. Jens Ehrhardt Group and its distribution partners may receive reimbursements from costs charged to the funds by the investment companies in accordance with the respective prospectuses. The units of this fund that are issued may only be sold or offered for sale in jurisdictions in which such offer or sale is permitted. Therefore the units of this fund may not be offered for sale or sold in the USA, or offered for sale or sold to or for the account of US citizens or US persons resident in the USA. This document and the information it contains may not be distributed in the USA. The distribution and publication of this document and the offer or sale of units may also be subject to restrictions in other jurisdictions.

*) © 2016 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.